Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATAI LIFE SCIENCES N.V.

(ATAI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness the Power of Innovative Mental Health Approaches for Positive Social Change

10/19/2021 | 07:00am EST

atai Life Sciences announced the launch of its new philanthropic program, atai Impact, in line with atai Life Sciences’ vision, to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. atai Impact has been developed to harness the power of innovative mental health approaches for positive social change, committed to advancing education, expanding access and supporting the wider ecosystem. Its establishment is based on atai Life Sciences’ position that, while a for-profit model is the swiftest and most robust means of unlocking new modalities for patients in need, this model alone cannot address all aspects of the escalating global mental crisis.


© S&P Capital IQ 2021
All news about ATAI LIFE SCIENCES N.V.
08:34aAtai Life Sciences Boosts Stake in Compass Pathways
MT
07:00aAtai Life Sciences Increases its Ownership Position in COMPASS Pathways
AQ
11/22HC Wainwright Adjusts Atai Life Sciences to $50 From $40, Reiterates Buy Rating
MT
11/17Berenberg Bank Adjusts Atai Life Sciences' Price Target to $38 From $35, Maintains Buy ..
MT
11/16RBC Trims Price Target on Atai Life Sciences to $17 From $19, Maintains Sector Perform ..
MT
11/15ATAI LIFE SCIENCES N.V. Management's Discussion and Analysis of Financial Condition an..
AQ
11/15European ADRs Move Slightly Higher in Monday Trading
MT
11/15ATAI Life Sciences' Q3 Loss Narrows
MT
11/15ATAI LIFE SCIENCES N : Reports Third Quarter 2021 Financial Results and Corporate Update -..
PU
11/15Atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
AQ
More news
Analyst Recommendations on ATAI LIFE SCIENCES N.V.
More recommendations
Financials (USD)
Sales 2021 18,4 M - -
Net income 2021 -118 M - -
Net cash 2021 407 M - -
P/E ratio 2021 -13,5x
Yield 2021 -
Capitalization 1 794 M 1 794 M -
EV / Sales 2021 75,3x
EV / Sales 2022 22 224x
Nbr of Employees 35
Free-Float 90,8%
Chart ATAI LIFE SCIENCES N.V.
Duration : Period :
Atai Life Sciences N.V. Technical Analysis Chart | ATAI | NL0015000DX5 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 11,19 $
Average target price 30,33 $
Spread / Average Target 171%
EPS Revisions
Managers and Directors
Florian Brand Chief Executive Officer
Gregory L. Weaver Chief Financial Officer
Srinivas G. Rao Chief Scientific Officer
Rolando Gutíerrez-Esteinou Chief Medical Officer
Alexis Marc Joel Louis de Rosnay Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ATAI LIFE SCIENCES N.V.0.00%1 794
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431